drugset / Trial / NCT01964859
Feasibility Study for Fibroblast Autologous Skin Grafts
Phase 2
Recruiting
80 enrolled
Johns Hopkins University
Maryland Stem Cell Research Fund · collabNational Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) · collabNational Institutes of Health (NIH) · collabUnited States Department of Defense · collab
NaSingle-groupOpen-labelBasic science
Summary
This research is being done to determine if investigators can change skin from one type to another. Specifically, investigators are interested in making normal skin into the thicker skin found on our palms and soles.
Timeline
- Start
- 2015-01-07
- Primary completion
- 2027-12-02
- Completion
- 2028-11-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Autologous Skin Fibroblasts | Cell therapy | — | Other |
| Subject | Bellafill | Unknown | — | — |
Indications
No indication recorded.